Origin Agritech Limited
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Weibin Yan
- Full Time Employees
- 68
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Address
- No. 21 Sheng Ming Yuan Road Beijing People's Republic of China 102206
- IPO Date
- Mar 29, 2004
- CIK
- 0001321851
- Website
- originseed.com.cn
- Similar Companies
- Business
- Origin Agritech Limited (NASDAQ: SEED), founded in 1997 and headquartered in Beijing, China, operates as a leading agricultural biotechnology company focused on the research, development, production, and distribution of hybrid crop seeds; it specializes in genetic improvement technologies including transgenic corn with phytase traits, glyphosate tolerance, insect resistance (Bt), and stacked gene combinations, alongside conventional and gene-edited corn varieties such as Jingke 317, Jinqiao 8, Xundan 203, and Aoyu 728; the company also offers molecular marker-assisted breeding, doubled haploid technologies, and technical consulting services to farmers primarily in the People's Republic of China, with international collaborations extending to markets like the United States. Origin maintains vertically integrated operations through facilities including the Origin Life Science Research Center in Beijing's Zhong-Guan-Cun Life Science Park, a southern breeding center in Hainan, and a seed R&D center in Tongzhou, Beijing; its product pipeline emphasizes corn seed biotechnology to enhance yields, pest resistance, drought tolerance, lodging resistance, and sustainability for animal feed and industrial uses amid China's food security demands. Recent developments include the Hi3 haploid induction line gene-editing technology recognized as one of the Top 10 Major Progresses in Chinese Agricultural Science for 2025 by the Chinese Academy of Agricultural Sciences, with over 10 improved maize induction lines developed for commercialization; in November 2025, Origin strengthened its gene-editing platform via a patent license agreement with Shandong Shunfeng Biotechnology for the Cas-SF01 system; September 2025 investments totaled approximately $3.88 million, comprising $2.4 million from CEO Weibin Yan and $1.48 million from institutional investors to bolster R&D and market expansion; the company launched full-scale seed processing in Xinjiang, established the Origin Marker Biological Breeding Service Consortium with China Agricultural University and 12 agricultural firms, and advanced GMO corn hybrids toward approvals in 2025-2026.
Origin Agritech Co-Authors Plant Biotechnology Journal Study That Breaks the Long-Standing Trade-Off Between Early-Maturing and High-Yield Corn
Origin Agritech Limited (SEED) Q2 2026 Earnings Call Transcript
Origin Agritech Announces Financial Results for the First Half of Fiscal Year 2026
Origin Agritech to Hold Business Update & First Half Fiscal Year 2026 Earnings Conference Call on May 22 at 8 a.m. ET
Origin Agritech (NASDAQ:SEED) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell?
Origin Agritech Launches Redesigned Corporate Website to Better Serve Partners, Customers, and Investors
Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer
Origin Agritech (NASDAQ:SEED) Stock Crosses Above 200-Day Moving Average – What’s Next?
Origin Agritech Launches "Aoyun 2026" New Variety Promotion Program to Drive Commercialization of Next-Generation Seed Varieties
Origin Agritech Announces Fiscal Year 2025 Results
Origin Agritech to Hold Business Update & Fiscal Year 2025 Earnings Conference Call on Monday, February 2 at 8 a.m. ET
Origin Agritech Holds Annual R&D and Operations Management Conference, Establishes 2026 Strategic Priorities
Head to Head Comparison: Origin Agritech (NASDAQ:SEED) & AgriFORCE Growing Systems (NASDAQ:AGRI)
Origin Agritech's Pioneering Hi3 Gene Editing Technology Awarded as Top 10 Major Progress in Chinese Agricultural Science for 2025, as Company Advances Commercialization
Origin Agritech Strengthens Gene Editing Platform through Patent License Agreement with Shunfeng BioTech
Origin Agritech Obtains New Licenses for Crop Seed Production and GMO Business Operations
Origin Agritech Executes Northeast China Market Re-Entry with Product Showcase and Technology Seminar
Origin Agritech Announces Investment Agreements, Including Investment from Origin CEO Weibin Yan
Origin Agritech Announces Appointment of Two New Independent Directors and Board Restructuring
Origin Agritech Commences Full-Scale Seed Processing Operations at Xinjiang Production Base